Navigation Links
Boehringer Ingelheim Cares Foundation Launches Online Giving Report
Date:2/25/2013

RIDGEFIELD, Conn, Feb. 25, 2013 /PRNewswire/ -- Boehringer Ingelheim Cares Foundation today announced that it has published its first online Giving Report, which is available at http://givingreport.us.boehringer-ingelheim.com.  The Giving Report summarizes through short stories, pictures and videos the four primary ways the Foundation makes more health: the donation of our medicine, our support of and engagement in community programs, the time and skills employees donate in our employee volunteer program, and our advocacy of social enterprise as an innovative way to solve problems and forge lasting change in our communities and society at large.

"Boehringer Ingelheim Cares Foundation aims to make more health for people in need," said Lilly Ackley , President, Boehringer Ingelheim Cares Foundation.  "Our Giving Report provides an overview of the philanthropic programs and partnerships we invest in to help patients and their families and strengthen our communities."

In the report, visitors will learn about a variety of programs and profiles including:

  • Our giving through our Patient Assistance Program and Product Donation Program
  • A patient story and video about the Boehringer Ingelheim AmeriCares Free Clinic
  • Employee skills-based volunteerism to help local nonprofits
  • Our global collaboration with Ashoka to support healthcare innovation through social enterprise

About Boehringer Ingelheim Cares Foundation

Boehringer Ingelheim Cares Foundation is a private foundation with a mission to provide "more health" to patients, families and communities through its four major programs: 

1) A Patient Assistance Program that makes our branded medicines available free of charge to patients without prescription insurance coverage who meet certain household income criteria

2) A Product Donation Program that donates BI medicines to approved nonprofit partners who meet certain standards, and who distribute the medicines around the world where there is tremendous unmet need

3) A Financial Contributions Program that provides financial support to Connecticut programs that improve access to healthcare and enhance math and science education for the underserved 

4) A Volunteer Program through which employees choose causes that are important to them and donate their time to strengthen our communities 

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.

As a central element of its culture, Boehringer Ingelheim has a demonstrated commitment to corporate social responsibility. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.


'/>"/>
SOURCE Boehringer Ingelheim Cares Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... YORK , Feb. 9, 2016 The life ... Langone Medical Center, has been anything but ordinary.  Twists of ... of World War II and the constraints of communist Czechoslovakia ... 1960s; there, he would go on to make history by ... the three best-selling drugs in the world, Remicade.  Dr. Vilcek ...
(Date:2/9/2016)... LONDON , Feb. 9, 2016 The new report ... Forecast: 2015-2019" by Spearhead Acuity Business Research & Consulting group reveals ... fetal and neonatal market with a share of 36.4% in 2014 ... North America , the report also covers market analysis for ... Europe , Asia-Pacific , ...
(Date:2/9/2016)... report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - 2019" ... North America continued to lead global anti-bacterial ... into revenues worth US$ 16,907.3 million. North ... , Latin America , Middle-East ... market is inclined towards North America and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused ... full year ended December 31, 2015 on Monday, February 29, 2016 after the market ... community following the release at 4:30 PM ET. Investors interested in participating by phone ...
(Date:2/10/2016)... ... February 10, 2016 , ... A ... Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's Bureau ... Center. , As the longest running and largest worker's compensation event in ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... and most versatile series of monitor mounts ever. , “Our goal was to ... and easy to install system that we have ever created.” said Darren Hulsey, Product ...
(Date:2/10/2016)... ... February 09, 2016 , ... Western University of Health ... screenings to 150 children in kindergarten through third grade at Hurley Elementary School ... joined Chinese American Dental Society of Southern California volunteers for Give Kids A ...
(Date:2/9/2016)... ... 2016 , ... Steven Douglas Associates is a sponsor of the What's Your ... held in South Florida. The Inaugural What’s Your Taste event will have a new, ... be held in a new, more causal format at the Fort Lauderdale home of ...
Breaking Medicine News(10 mins):